"In accordance with the New York State Department of Health, we are requiring all hospital visitors to follow specific visitation guidelines for the safety of our patients, visitors and team members. Please visit our website to learn more. Zucker Hillside Hospital is Northwell Health's nationally recognized behavioral health center known for its pioneering clinical, teaching and research programs. The National Institutes of Health has established a Clinical Research Center for the Study of Schizophrenia at Zucker Hillside Hospital, one of only four such facilities nationwide."

During the past decade, The Zucker Hillside Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Zucker Hillside Hospital" #1 sponsor was "Northwell Health" with 30 trials, followed by "Corcept Therapeutics" with 3 trials sponsored, "Dartmouth-Hitchcock Medical Center" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Nathan Kline Institute for Psychiatric Research" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Zucker Hillside Hospital" #1 collaborator was "National Institute of Mental Health (NIMH)" with 16 trials as a collaborator, "The Zucker Hillside Hospital" with 6 trials as a collaborator, "National Alliance for Research on Schizophrenia and Depression" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "Winterlight Labs" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "The Zucker Hillside Hospital" are "Schizophrenia" (23 trials), "Schizoaffective Disorder" (11 trials), "Bipolar Disorder" (8 trials), "Psychosis" (5 trials) and "Psychotic Disorders" (5 trials). Many other conditions were trialed in "The Zucker Hillside Hospital" in a lesser frequency.

Most popular intervention types in "The Zucker Hillside Hospital" are "Drug" (36 trials), "Other" (12 trials), "Behavioral" (9 trials), "Device" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Risperidone" (5 trials), "Aripiprazole" (3 trials), "placebo" (3 trials) and "Behavioral Intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Zucker Hillside Hospital" are 56 trials for "All" genders.

Currently, there are NaN active trials in "The Zucker Hillside Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in The Zucker Hillside Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Zucker Hillside Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 20 trials that are defined as “Not Applicable".